| Barbara Jean Haley, MD | |
|
5323 Harry Hines Blvd, Dallas, TX 75390-7208 | |
| (214) 645-8600 | |
| Not Available |
| Full Name | Barbara Jean Haley |
|---|---|
| Gender | Female |
| Speciality | Hematology/oncology |
| Experience | 48 Years |
| Location | 5323 Harry Hines Blvd, Dallas, Texas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1518936087 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | E6395 (Texas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Ut Southwestern University Hospital - William P. Clements Jr. | Dallas, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Of Texas Southwestern Medical Center | 0648188250 | 2588 |
News Archive
Regeneron Pharmaceuticals, Inc. and Sanofi today announced that the U.S. Food and Drug Administration approved Praluent (alirocumab) Injection, the first FDA-approved treatment in a new class of drugs known as PCSK9 (proprotein convertase subtilisin/kexin type 9) inhibitors.
eHealth/Commonwealth Fund: National Progress Report On eHealth - This extensive report examines changes in the adoption and use of health information technology (HIT) since 2007, as assessed by a group of more than 100 experts.
The American Society for Reproductive Medicine (ASRM) today issued a report on new techniques designed to preserve a women's fertility after cancer treatments by using egg or ovarian tissue freezing technology.
Neogen Corporation today announced that its rapid test for Salmonella enteritidis (SE) has received approval from AOAC International.
› Verified 3 days ago
| Entity Name | University Of Texas Southwestern Medical Center At Dallas |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1972579365 PECOS PAC ID: 0648188250 Enrollment ID: O20031106000792 |
News Archive
Regeneron Pharmaceuticals, Inc. and Sanofi today announced that the U.S. Food and Drug Administration approved Praluent (alirocumab) Injection, the first FDA-approved treatment in a new class of drugs known as PCSK9 (proprotein convertase subtilisin/kexin type 9) inhibitors.
eHealth/Commonwealth Fund: National Progress Report On eHealth - This extensive report examines changes in the adoption and use of health information technology (HIT) since 2007, as assessed by a group of more than 100 experts.
The American Society for Reproductive Medicine (ASRM) today issued a report on new techniques designed to preserve a women's fertility after cancer treatments by using egg or ovarian tissue freezing technology.
Neogen Corporation today announced that its rapid test for Salmonella enteritidis (SE) has received approval from AOAC International.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Barbara Jean Haley, MD Po Box 845347, Dallas, TX 75284-5347 Ph: (214) 645-8600 | Barbara Jean Haley, MD 5323 Harry Hines Blvd, Dallas, TX 75390-7208 Ph: (214) 645-8600 |
News Archive
Regeneron Pharmaceuticals, Inc. and Sanofi today announced that the U.S. Food and Drug Administration approved Praluent (alirocumab) Injection, the first FDA-approved treatment in a new class of drugs known as PCSK9 (proprotein convertase subtilisin/kexin type 9) inhibitors.
eHealth/Commonwealth Fund: National Progress Report On eHealth - This extensive report examines changes in the adoption and use of health information technology (HIT) since 2007, as assessed by a group of more than 100 experts.
The American Society for Reproductive Medicine (ASRM) today issued a report on new techniques designed to preserve a women's fertility after cancer treatments by using egg or ovarian tissue freezing technology.
Neogen Corporation today announced that its rapid test for Salmonella enteritidis (SE) has received approval from AOAC International.
› Verified 3 days ago
Uma B.r.k Pakkivenkata, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 9900 N Central Expy Ste 215, Dallas, TX 75231 Phone: 214-396-4950 Fax: 877-423-5360 | |
Dr. Ariel Marcelo Modrykamien, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 3600 Gaston Ave, Wadley Tower, Suite 960, Dallas, TX 75246 Phone: 402-972-6078 | |
Benjamin Seth Martinez, MD Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 5323 Harry Hines Blvd, Dallas, TX 75390 Phone: 214-648-3111 Fax: 214-648-5461 | |
Vijaya Mummadi, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 9900 N Central Expy Ste 225, Dallas, TX 75231 Phone: 469-646-8880 Fax: 469-646-8884 | |
Dr. Ting-yi Chen, M.D. Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 5323 Harry Hines Blvd, Dallas, TX 75390 Phone: 214-645-2800 Fax: 214-645-2808 | |
William Cook Langmade, MD Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 1441 N Beckley Ave, Dallas, TX 75203 Phone: 214-947-2306 | |
Dr. Janame J Kottey, MBBS Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 13154 Coit Rd Ste 100, Dallas, TX 75240 Phone: 214-358-2300 Fax: 214-579-6989 |